Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA CIPLA ASTRAZENECA PHARMA/
CIPLA
 
P/E (TTM) x 91.1 33.7 270.5% View Chart
P/BV x 16.5 4.3 385.4% View Chart
Dividend Yield % 0.3 0.5 65.6%  

Financials

 ASTRAZENECA PHARMA   CIPLA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
CIPLA
Mar-22
ASTRAZENECA PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs4,5801,083 422.8%   
Low Rs2,529806 313.7%   
Sales per share (Unadj.) Rs322.2269.7 119.5%  
Earnings per share (Unadj.) Rs24.631.7 77.7%  
Cash flow per share (Unadj.) Rs31.444.8 70.2%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Avg Dividend yield %0.30.5 53.2%  
Book value per share (Unadj.) Rs203.8257.8 79.1%  
Shares outstanding (eoy) m25.00806.81 3.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.03.5 315.0%   
Avg P/E ratio x144.329.8 484.4%  
P/CF ratio (eoy) x113.121.1 536.0%  
Price / Book Value ratio x17.43.7 476.0%  
Dividend payout %40.615.8 257.5%   
Avg Mkt Cap Rs m88,863762,177 11.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,30235,299 6.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,056217,633 3.7%  
Other income Rs m1483,217 4.6%   
Total revenues Rs m8,204220,851 3.7%   
Gross profit Rs m86243,298 2.0%  
Depreciation Rs m17010,520 1.6%   
Interest Rs m101,064 0.9%   
Profit before tax Rs m83034,933 2.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2149,338 2.3%   
Profit after tax Rs m61625,595 2.4%  
Gross profit margin %10.719.9 53.8%  
Effective tax rate %25.826.7 96.6%   
Net profit margin %7.611.8 65.0%  
BALANCE SHEET DATA
Current assets Rs m7,653147,108 5.2%   
Current liabilities Rs m3,92349,129 8.0%   
Net working cap to sales %46.345.0 102.8%  
Current ratio x2.03.0 65.2%  
Inventory Days Days6163 97.5%  
Debtors Days Days396 677.6%  
Net fixed assets Rs m2,120119,415 1.8%   
Share capital Rs m501,614 3.1%   
"Free" reserves Rs m5,044206,364 2.4%   
Net worth Rs m5,094207,977 2.4%   
Long term debt Rs m04,162 0.0%   
Total assets Rs m9,773266,523 3.7%  
Interest coverage x88.433.8 261.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.8 100.9%   
Return on assets %6.410.0 64.0%  
Return on equity %12.112.3 98.3%  
Return on capital %16.517.0 97.2%  
Exports to sales %026.2 0.0%   
Imports to sales %31.78.2 387.2%   
Exports (fob) Rs mNA57,094 0.0%   
Imports (cif) Rs m2,55217,803 14.3%   
Fx inflow Rs m44260,180 0.7%   
Fx outflow Rs m2,55217,803 14.3%   
Net fx Rs m-2,11042,376 -5.0%   
CASH FLOW
From Operations Rs m1,00833,259 3.0%  
From Investments Rs m47-18,719 -0.3%  
From Financial Activity Rs m-95-15,998 0.6%  
Net Cashflow Rs m961-1,323 -72.6%  

Share Holding

Indian Promoters % 0.0 13.5 -  
Foreign collaborators % 75.0 20.1 372.6%  
Indian inst/Mut Fund % 3.8 49.4 7.7%  
FIIs % 2.5 27.7 9.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 66.4 37.7%  
Shareholders   49,085 388,864 12.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    


More on ASTRAZENECA PHARMA vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Cipla Share Price Performance

Period ASTRAZENECA PHARMA Cipla S&P BSE HEALTHCARE
1-Day -0.02% -0.35% 0.23%
1-Month 2.02% -4.65% 0.36%
1-Year 3.02% 14.22% -6.87%
3-Year CAGR 7.94% 33.00% 20.16%
5-Year CAGR 24.01% 12.52% 11.07%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Cipla the stake stands at 33.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

Cipla paid Rs 5.0, and its dividend payout ratio stood at 15.8%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Gains 211 Points | Tyre Stocks Rally while Metals Drag | 4 Reasons Why Indian Share Markets Hit Record High(Closing)

After opening the day lower mirroring weakness in Asian peers, Indian share markets staged a comeback and ended the trading session on an optimistic note.